Subscribe To
Shell gets largest share of new north sea licences
A further 27 North Sea licences awards were announced today as Rishi Sunak's retreat from the climate goals championed by his predecessors continued. ...
October 30, 2023, 9:04 am
Artelo biosciences selected for oral presentation to report positive research findings on art12.11 at the 33rd annual international cannabinoid research society symposium
ART12.11, a Novel and Patented Cocrystal of Cannabidiol, Improves Bioavailability and Efficacy of CBD ART12.11, a Novel and Patented Cocrystal of Can...
June 7, 2023, 8:30 am
Theriva biologics reports first quarter 2023 operational highlights and financial results
– Continued to enroll patients in VIRAGE, the Phase 2b clinical trial of systemically administered VCN-01 in combination with chemotherapy for Pancr...
May 11, 2023, 12:00 pm
Shell, bp new north sea licences hang in the balance at high court ruling
Climate activists will be told whether a case for the UK to scrap the latest North Sea oil and gas licensing round can proceed in Britain's High Court...
April 25, 2023, 6:42 am
Spero therapeutics to present data at the 33rd european congress of clinical microbiology and infectious diseases
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
April 14, 2023, 12:05 pm
Spero therapeutics to present data at the 33rd european congress of clinical microbiology and infectious diseases
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
April 14, 2023, 8:05 am
Novan to present at the oppenheimer 33rd annual healthcare conference
Presentation with live webcast today, March 14th at 10:40 AM ET Presentation with live webcast today, March 14th at 10:40 AM ET...
March 14, 2023, 8:30 am
Amgen inc. (amgn) oppenheimer 33rd annual healthcare conference (transcript)
Amgen Inc. (NASDAQ:AMGN ) Oppenheimer 33rd Annual Healthcare Conference March 13, 2023 2:00 PM ET Compa...
March 13, 2023, 3:27 pm
Diamedica therapeutics to present at the oppenheimer 33rd annual healthcare conference
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...
March 13, 2023, 8:00 am
Amgen to present at the 33rd annual oppenheimer healthcare conference
THOUSAND OAKS, Calif., March 9, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m....
March 9, 2023, 5:33 pm
Amgen to present at the 33rd annual oppenheimer healthcare conference
THOUSAND OAKS, Calif. , March 9, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m....
March 9, 2023, 5:20 pm
Butterfly network to present at the 33rd annual oppenheimer healthcare conference
BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a digital health company transforming care with handheld, whol...
March 8, 2023, 5:00 pm
Viracta therapeutics to present at the 33rd annual oppenheimer healthcare conference
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and pre...
March 8, 2023, 4:05 pm
Kala pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
ARLINGTON, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to...
March 8, 2023, 4:01 pm
Chinook therapeutics to present at the oppenheimer 33rd annual healthcare conference
SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developme...
March 7, 2023, 4:00 pm
Augmedix announces participation in oppenheimer’s 33rd annual healthcare conference
SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) — Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambie...
March 7, 2023, 12:00 pm
Veru to present at the oppenheimer 33rd annual healthcare conference
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-1...
March 7, 2023, 8:30 am
Enanta pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small mole...
March 7, 2023, 7:00 am
Eloxx pharmaceuticals to present at the oppenheimer 33rd annual healthcare conference
WATERTOWN, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies ...
March 6, 2023, 4:10 pm
Savara to present at the oppenheimer 33rd annual healthcare conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ann...
March 6, 2023, 4:05 pm